FIDELITY & GUARANTY LIFE INSURANCE CO sold $589K of CCAP

FIDELITY & GUARANTY LIFE INSURANCE CO sold 56,285 shares of Crescent Capital BDC, Inc. (CCAP) at an average of $10.46 ($10.44–$10.50, $0.59M total) across 2 trades over 2026-09-01 to 2026-09-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · FIDELITY & GUARANTY LIFE INSURANCE CO
Published Sep 3, 2026, 3:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 3:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCAP
Neutral
medium confidence
Mentioned
$CCAP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCAPNeutralLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings but is unlikely to move the stock materially.

02

Market read

Primary insider sale with modest size; limited trading relevance.

03

What to watch

Potential tax planning or portfolio rebalancing motives behind the 10b5‑1 execution.

Relevance 4/10Novelty 5/10Timing: filing today (2026‑09‑03)

Background

Form 4 filings disclose insider transactions; a 10% owner selling shares via a pre‑arranged plan is standard reporting.

Company-level read

Ticker impact

$CCAPNeutralMedium confidence
Context

Fidelity & Guaranty Life Insurance sold 56,285 shares of Crescent Capital BDC, Inc. (CCAP) via a 10b5‑1 plan, reducing its stake to 3,961,279 shares.

Expected impact

Limited short‑term price pressure; may cause slight downside if market interprets as lack of confidence.

Evidence & confidence

Sale size (~$0.59 M) is small relative to market cap; insider is a large holder but used a pre‑arranged plan, reducing informational value.

Market effects

Minor impact on BDC sector; no broader industry signal.

U.S. market only; no regional effect.

Low relevance globally.

Counterpoint

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • Crescent Capital BDC, Inc.

    Business development company listed on NYSE under ticker CCAP.

  • Fidelity & Guaranty Life Insurance Co.

    10% owner of CCAP executing a 10b5‑1 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36